New Biosimilar Registration in South America
Orphamed successfully completes registration of key biosimilar products in major South American markets, expanding access to affordable biologics.
Read More →Connecting manufacturers with distributors across Eastern Europe, MENA, North Africa, South America, and South Asia through expert regulatory guidance and market access solutions.
Target Countries
Product Registrations
Years Experience
Your trusted partner in pharmaceutical market expansion across emerging markets
Orphamed serves as a strategic bridge between pharmaceutical manufacturers and distributors across Eastern Europe, MENA, North Africa, South America, and South Asia regions.
With deep expertise in regulatory affairs, market access, and distribution management, we specialize in biosimilars and oncology products, ensuring seamless market entry and sustained growth.
Our comprehensive approach combines regulatory excellence with local market insights, delivering end-to-end solutions that accelerate your market expansion while maintaining the highest quality standards.
15+ target countries across three strategic regions
Biosimilars and oncology expertise
EU GMP and PICS GMP compliance
Long-term strategic relationships
Comprehensive solutions for pharmaceutical market expansion
Complete tender process management from preparation to award, ensuring competitive positioning and optimal outcomes.
Expert guidance through complex regulatory landscapes, ensuring compliance and expedited approvals.
End-to-end export solutions covering logistics, documentation, and supply chain optimization.
Seamless technology transfer services facilitating knowledge sharing and local manufacturing capabilities.
Comprehensive range of biosimilars, oncological products, and radiology solutions
Advanced biologics for autoimmune disorders and oncology - Our Primary Focus
Comprehensive cancer treatment solutions
Advanced imaging solutions for diagnostic procedures
Quality Assurance: All products manufactured under EU GMP & PICS GMP standards
Regulatory: Products available for registration in Eastern Europe, MENA, North Africa, South America, and South Asia regions
Download our comprehensive product portfolio with detailed specifications
Stay informed about our latest developments and industry insights
Orphamed successfully completes registration of key biosimilar products in major South American markets, expanding access to affordable biologics.
Read More →Strategic collaboration agreements signed with leading distributors across North African region to enhance market penetration.
Read More →All manufacturing facilities successfully pass EU GMP inspection, maintaining highest quality standards for our product portfolio.
Read More →Ready to expand your market presence? Get in touch with our experts